Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.
Galloway SAE, Dolton G, Attaf M, Wall A, Fuller A, Rius C, Bianchi V, Theaker S, Lloyd A, Caillaud ME, Svane IM, Donia M, Cole DK, Szomolay B, Rizkallah P, Sewell AK.
Galloway SAE, et al. Among authors: szomolay b.
Front Immunol. 2019 Mar 13;10:319. doi: 10.3389/fimmu.2019.00319. eCollection 2019.
Front Immunol. 2019.
PMID: 30930889
Free PMC article.